Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
441
+13
+3% +$6K 0.15% 127
2026
Q1
$206K Hold
428
0.15% 135
2025
Q4
$240K Sell
428
-19
-4% -$10.8K 0.16% 126
2025
Q3
$230K Buy
+447
New +$195K 0.15% 134

Other funds holding MEDP

Renasant Bank's MEDP Position: Q2 2026 in Review

Renasant Bank increased its Medpace (MEDP) stake by 3% in Q2 2026, buying an estimated $6K and bringing the position to 441 shares worth $234K. The position accounts for 0.15% of the portfolio, ranked #127.

Renasant Bank first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $240K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Renasant Bank held 441 shares of Medpace worth $234K as of Q2 2026.
  • Renasant Bank bought 13 Medpace shares in Q2 2026, an estimated $6K.
  • Medpace made up 0.15% of Renasant Bank's portfolio in Q2 2026, its #127 holding.
  • Renasant Bank first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Renasant Bank's Medpace position peaked at $240K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Renasant Bank's 13F filing for Q2 2026, filed 11 Aug 2026.